The examination of ERBB2 copy numbers is of emerging diagnostic value, because amplifications of ERBB2 are a potential therapeutic target for metastatic CRC and have shown to be involved in acquired resistance to anti-EGFR antibodies51,52. The gene discussed is EGFR; the disease is colorectal carcinoma.